• Clinical Trials Adrift in the Age of Social Media

    Clinical Research News | Many forces outside of the healthcare setting shape people’s decisions about whether to join or stay in a clinical trial or comply with study-related requirements. While no strong evidence exists that influencers on social media are impacting the integrity of trials, it has become self-evident that they have the power to undermine the authority of traditional sources of information and their sway is therefore an issue “very deserving of our attention."

    Jun 13, 2024

  • Watching the State of Clinical Trial Data Compliance

    Clinical Research News | Until relatively recently, clinical-trial submissions in the EU had to be made separately to each applicable member-state’s authority. The process was inefficient and laborious, resulting in a lot of complaints from clinical-research organizations. On January 31, 2022, the EU Clinical Trials Regulation came into effect.

    Jun 11, 2024

  • ‘Continuity’ and Why It’s Now Critical for Successful Ophthalmic Clinical Trials

    Clinical Research News | Ophthalmic clinical trials are expanding in global reach, incorporating a wide range of geographical areas, sites, personnel, and imaging technologies. Maintaining data integrity, imaging reliability, process efficiency, and regulatory compliance across these multi-faceted environments can be quite challenging—and is why continuity across image collection, processing, and management is now a fundamental “must-have” for ophthalmic clinical trial success.

    Jun 7, 2024

  • AI Model Estimates Treatment Effect on Par With Clinical Trials

    Clinical Research News | Researchers at The Ohio State University (OSU) have been using artificial intelligence (AI) for several years now to emulate clinical trials by crunching real-world data (RWD). In their latest computational feat, they succeeded in precisely estimating results of randomized clinical trials comparing the effectiveness of two treatments for reducing the risk of stroke after coronary artery disease.

    Jun 6, 2024

  • Blood Test Could Improve Diagnosis of Severe Strokes on a Global Scale

    Clinical Research News | Researchers at The Ohio State University (OSU) have been using artificial intelligence (AI) for several years now to emulate clinical trials by crunching real-world data (RWD). In their latest computational feat, they succeeded in precisely estimating results of randomized clinical trials comparing the effectiveness of two treatments for reducing the risk of stroke after coronary artery disease.

    Jun 4, 2024

  • American Clinical Research Services Acquires Elixia, Oxford BioDynamics, King’s College London Collaborate, Recursion’s Supercomputer Ranked, More

    Clinical Research News | American Clinical Research Services has acquired Elixia; Oxford BioDynamics and King's College London are teaming up in the immediate follow up of the APIPPRA trial, the largest RA prevention trial to date; Recursion’s BioHive-2 was dubbed No. 35 on the latest TOP500 list of the world’s fastest supercomputers; more.

    May 29, 2024